Nicole Sweeny, Chief Commercial Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 1,489 shares at $26.78 ($40K) on 2026-05-26, disclosed to the SEC on 2026-05-27.
Open-market sale of $40k KALV by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KALV | SELL | 2026-02-24 | $124K | — | Filing → |
| KALV | SELL | 2025-12-04 | $103K | — | Filing → |
| KALV | SELL | 2025-08-26 | $20K | — | Filing → |